Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib-Tramadol for Acute Pain After Impacted Third Molar Extraction
NCT05995912Phase 2Completed
- Sponsor
- Laboratorios Liomont
- Start
- Sep 2021
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of etoricoxib + tramadol in acute postoperative pain, sponsored by Laboratorios Liomont. Started Sep 2021; status: completed.
02
Drugs
etoricoxib + tramadol
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT05995912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995912.